REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/13/2026
Back to search
Official data from USPTO
ALLERGAN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
07/13/2026
Trademark type
Word
Nice classes
5, 10
Filing date
01/03/2018
Registration date
07/13/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/13/2021
Last transaction
07/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/30/2017
First use in commerce
06/30/2017
Drawing code
4
Owner type
16
Owner location
Madison, NJ, US
Examiner
CLARK, ROBERT C
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Allergan Sales, LLC
Representatives
Matthew O. Brady AbbVie Inc.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark used for a line of pharmaceuticals used in connection with anti-agingthe treatment of glabellar linesfacial wrinklesasymmetries and defects and conditions of the human skinfacial aesthetic surgeryfacial aesthetic reconstructionbreast aesthetics; topical antibioticsanti-inflammatoryanti-infectiveanti-glaucoma and decongestant formulationspharmaceutical preparations to treat and prevent glaucoma; ocular wetting solutionseye dropsartificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disordersmuscle dystoniassmooth muscle disordersautonomic nerve disordersheadacheshyperhydrosissports injuriescerebral palsyspasmstremors and pain; dermatological formulationsmedicated dry skin lotions and creamsacne medications and medicated skin lighteners; Oraltransdermalinjectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tractgastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that supportencourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's diseasedementiaAIDS-related dementiacentral nervous system disordersneurological disordersneurodegenerative disordersdepressionneuroprotective agent; antidepressants; pharmaceuticalsantipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals and cosmeceuticalsmedicated skin cleanserstonersmoisturizersrejuvenatorsrehydrating creamslotions for the face and body; medicated cosmetic skin care preparations
Class 10
House mark used for a line of surgicalmedicaldental and veterinary apparatus and instrumentsdiagnostic test kits principally composed of medical diagnostic meters that measure conditions of the cardio-vascular and immune systems; intra-uterine non-chemical contraceptive devices; medical diagnostic instruments for the analysis of body fluids; medical devices for treating glabellar linesfacial wrinklesasymmetries and defects and conditions of the human skinfor use in facial aesthetic surgeryfacial aesthetic reconstructionbreast aesthetics and ophthalmic related diseases and disorders
Publications
History of USPTO decisions and trademark events.
41 publications found
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/06/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/06/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/06/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/06/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
07/13/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/09/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/08/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/07/2021
IUAF
USE AMENDMENT FILED
06/04/2021
EISU
TEAS STATEMENT OF USE RECEIVED
06/04/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/30/2020
EX5G
SOU EXTENSION 5 GRANTED
12/29/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/29/2020
EXT5
SOU EXTENSION 5 FILED
12/10/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/10/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/16/2020
EX4G
SOU EXTENSION 4 GRANTED
06/12/2020
EXT4
SOU EXTENSION 4 FILED
06/12/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/12/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/10/2019
EX3G
SOU EXTENSION 3 GRANTED
12/06/2019
EXT3
SOU EXTENSION 3 FILED
12/06/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/06/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/14/2019
EX2G
SOU EXTENSION 2 GRANTED
06/12/2019
EXT2
SOU EXTENSION 2 FILED
06/12/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/12/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/01/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/29/2018
EX1G
SOU EXTENSION 1 GRANTED
11/29/2018
EXT1
SOU EXTENSION 1 FILED
11/29/2018
EEXT
SOU TEAS EXTENSION RECEIVED
11/29/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/12/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/17/2018
PUBO
PUBLISHED FOR OPPOSITION
04/17/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/14/2018
DOCK
ASSIGNED TO EXAMINER
03/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/18/2018
NWAP
NEW APPLICATION ENTERED
01/06/2018
Continuous trademark protection
Get notified about every new filing that threatens ALLERGAN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.